about
Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhagePlatelet count, spleen length, and platelet count/spleen length ratio for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisTransient ultrasound elastography and magnetic resonance elastography for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisNon-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisCapsule endoscopy for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisMagnetic resonance imaging, computer tomography scan, and oesophagography for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisThrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusionComputed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhageThrombelastography (TEG) or Thrombelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusionBiomarker-Based Approaches for Assessing Alcohol Use DisordersResearching complementary and alternative treatments--the gatekeepers are not at homeThromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study.Blood test ordering for unexplained complaints in general practice: the VAMPIRE randomised clinical trial protocol. [ISRCTN55755886].Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosisComparison of approaches to estimate confidence intervals of post-test probabilities of diagnostic test results in a nested case-control studyFrom accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study.Skin cancer recognition by using a neuro-fuzzy systemLatent class bivariate model for the meta-analysis of diagnostic test accuracy studies.An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome.Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countriesThyroid function parameters in normal pregnancies in an iodine sufficient populationCurrent state and future directions of neurochemical biomarkers for Alzheimer's disease.An evidence-base for laboratory endocrinology?Diagnostic tools in male infertility-the question of sperm dysfunction.Adaption and application of the four phase trials to traditional chinese medicines.Carotid imaging for secondary stroke prevention in routine practice.Accuracy of diagnostic tests in multiple sclerosis--a systematic review.Monitoring patients at risk of massive transfusion with Thrombelastography or Thromboelastometry: a systematic review.Analytical and clinical evaluation of biomarkers assays: when are biomarkers ready for prime time?The architecture of diagnostic research: from bench to bedside--research guidelines using liver stiffness as an example.Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis.Microbiological diagnosis of community-acquired respiratory tract infections by nucleic acid detection.When and how should new technology be introduced into the IVF laboratory?Thromboelastography in patients with severe sepsis: a prospective cohort study.Trial sample size, but not trial quality, is associated with positive study outcome.Licensing diagnostic tests may benefit everyone.Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay.Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
P2860
Q24193421-57C31AF9-74D6-4AE6-888D-B7031046B52BQ24234737-74608517-6C2C-4B8F-9B79-07450FBFB121Q24234743-4FBEECB8-ED46-4FB7-8F04-EFD1A4D68C5CQ24234751-F9C95912-476B-4342-B66C-B6018F544CBFQ24234755-139185CF-B3BA-476D-BA05-282B4033278FQ24234767-DD4FDE47-1F80-45F7-B7FD-A4209E979F89Q24235742-E34C9EA4-35F3-4A8F-9494-A5D176EB51F9Q24236355-D3EB4496-0D86-45B9-80C5-6BCFDC5C9A2AQ24240465-C8C07E50-BE91-4AA8-B13C-3591AE7462AAQ26772931-BAF6F2A2-4A23-4483-93E2-1E326A25F884Q28218894-5F52ABE1-970F-4FA0-97DD-6CEECD9B7FBAQ30248341-4A267C50-20B6-44A9-BD65-673A79C8AEEFQ30540746-286DA05D-2569-4943-9AD8-7E18A3161578Q33237289-1AB692D3-BDF2-4D1C-86ED-3D8345246037Q34418793-F972B37B-AA9D-44E6-AAF0-1A381392D52AQ34462793-E54726AA-F9F2-4906-B320-C7E815F71AA2Q34569710-8FBEEE0F-7BBE-4041-BA0C-6E72B3883B1AQ34578613-125068B7-6F66-4FC0-99EB-954B4FA648C1Q35205720-C15B31C9-15BF-4F37-BDA3-5EBDA781EB24Q35771734-26F152A9-13B8-4C5E-B431-22D2417547B7Q35917744-32F682AB-BCE8-4028-B317-D3D5CB1691FFQ36323836-35DA5A4A-CBEF-4DB6-8E4F-BF85A73F9CD7Q36985933-441A4642-91A8-4363-A898-066FEC4CF6EBQ37020170-66C1558C-DBF6-4F82-9D5C-BF969C39D511Q37084752-F6965C66-05B6-4E0F-868A-DB7FC78D4656Q37145020-5A7D0746-7549-4992-BDE2-882ED538348FQ37244425-3F6A69F7-160B-41EE-A95D-261B306ABB18Q37808715-4E446F28-091F-4713-BD5E-DF031E05CFADQ37957187-AC5FBCAB-F367-4834-9110-6C3B62BF4CD7Q38132100-23EA004C-1AE1-43A6-85D8-3AC28331134DQ38166323-B52C2F41-227D-4743-81B9-66D77E34A472Q38384260-929FEE6F-84A2-4FAD-8F89-0630E3224D82Q40064963-B2C3FA4D-4AF5-42AF-9BAE-DD4B5708E402Q41606774-696C0DA9-0314-472F-A44E-2380ABFA4B92Q41654152-58631E2A-44C7-41A3-9F9B-4AAC33718D4EQ41889049-815614BC-0873-4DE5-9813-BED394164ECDQ43061722-F262DBD7-2036-4632-AB2A-442FB7FBE83AQ46188463-D93F410B-8D14-4F28-98E6-4909417A0EA6Q47142684-28B24CE3-8039-4982-A554-CFCC8EB746B0Q47373659-211F94B7-E307-4E25-A6AD-B539649E2C2E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evidence based diagnostics
@ast
Evidence based diagnostics
@en
type
label
Evidence based diagnostics
@ast
Evidence based diagnostics
@en
prefLabel
Evidence based diagnostics
@ast
Evidence based diagnostics
@en
P2860
P356
P1433
P1476
Evidence based diagnostics
@en
P2860
P304
P356
10.1136/BMJ.330.7493.724
P407
P577
2005-03-01T00:00:00Z